Our first discussion highlighted the risk of viral "immune escape" when using a prophylactic vaccine during a pandemic. This is a follow up interview to discuss some outstanding issues. Many further questions about the science around this risk have been raised and will be addressed during this presentation.

‍

Timecodes:

0:00 - Intro

7:52 - Intervention is needed

9:25 - Relatively advanced COVID vaccination programs

12:06 - Immune escape

18:55 - COVID antibodies

24:44 - Prophylactic COVID vaccine

36:48 - Where we go next

42:08 - Potential measures to address COVID pandemic

49:58 - Live COVID vaccines

54:46 - Good health and innate immunity

‍

Geert Vanden Bossche is an international expert in vaccine research and development, with a proven track record in designing and developing vaccines. He is proficient in vaccine patent writing, laboratory research, immunology, epidemiology, microbiology and preclinical vaccine development.

‍

Please add any questions or concerns in a comment and we will cover as many as possible during our discussion.

‍

The video of our first interview (March 6th, 2021) can be found here:

LinkedIn: https://www.linkedin.com/posts/dr-philip-anthony-mcmillan_covid-research-vaccine-activity-6773654721291927552-a2JN

‍YouTube: https://www.youtube.com/watch?v=ZJZxiNxYLpc

‍More innovative insights into COVID-19 are available here:

https://mcmillanresearch.com/